Some patients reported visual disturbances (e.g., blurred vision) associated with conjunctivitis or keratitis. Conjunctivitis and keratitis have been reported with DUPIXENT in postmarketing settings, predominantly in AD patients. Conjunctivitis also occurred more frequently in chronic rhinosinusitis with nasal polyposis subjects and prurigo nodularis subjects who received DUPIXENT compared to those who received placebo. If a clinically significant hypersensitivity reaction occurs, institute appropriate therapy and discontinue DUPIXENT.Ĭonjunctivitis and Keratitis: Conjunctivitis and keratitis occurred more frequently in atopic dermatitis subjects who received DUPIXENT versus placebo, with conjunctivitis being the most frequently reported eye disorder. Hypersensitivity: Hypersensitivity reactions, including anaphylaxis, serum sickness or serum sickness-like reactions, angioedema, generalized urticaria, rash, erythema nodosum, and erythema multiforme have been reported.
#XOLAIR CO PAY CARD FULL#
Please see Full Prescribing Information, including Boxed WARNING.CONTRAINDICATION: DUPIXENT is contraindicated in patients with known hypersensitivity to dupilumab or any of its excipients. You may report side effects to FDA at 1-80. These are not all the possible side effects of CINQAIR.Ĭall your doctor for medical advice about side effects.
The most common side effects of CINQAIR include throat pain. abnormal growth of cells or tissue in your body that may or may not be cancer (malignancy).See “What is the most important information I should know about CINQAIR?”.What are the possible side effects of CINQAIR?ĬINQAIR may cause serious side effects, including: Talk to your healthcare provider about the best way to feed your baby if you receive CINQAIR.ĭo not stop taking your other asthma medicines unless your healthcare provider tells you to. You and your healthcare provider should decide if you will receive CINQAIR and breastfeed. It is not known if CINQAIR passes into your breast milk. are breastfeeding or plan to breastfeed.Tell your healthcare provider if you become pregnant during your treatment with CINQAIR. It is not known if CINQAIR will harm your unborn baby. are pregnant or plan to become pregnant.This may cause other symptoms that were controlled by the corticosteroid medicine to come back. Do not stop taking your corticosteroid unless your healthcare provider tells you to stop. are taking oral or inhaled corticosteroid medicines.
See Full Prescribing Information for a complete list of the ingredients in CINQAIR.īefore receiving CINQAIR, tell your healthcare provider about all of your medical conditions, including if you: It is not known if CINQAIR is safe and effective in children less than 18 years of age.ĭo not receive CINQAIR if you are allergic to reslizumab or any of the ingredients in CINQAIR. CINQAIR is not used to treat sudden breathing problems.CINQAIR is not used to treat other problems caused by eosinophils.Eosinophils are a type of white blood cell that may contribute to your asthma. Medicines such as CINQAIR reduce blood eosinophils. When added to other medicines for asthma, CINQAIR helps prevent severe asthma attacks (exacerbations) and can improve your breathing. symptoms of low blood pressure (fainting, dizziness, light headedness, confusion, fast heart beat)ĬINQAIR is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in people aged 18 years of age and older whose asthma is not controlled with the current asthma medicines.swelling of your face, lips, mouth, or tongue.
Tell your healthcare provider right away if you have any of the following symptoms that may be associated with an allergic reaction: Your healthcare provider will watch you during and after you receive your CINQAIR infusion for any signs of a reaction. Allergic reactions sometimes do not happen right away.
Serious allergic reactions can happen right after you receive your CINQAIR infusion. Serious allergic reactions (anaphylaxis).
0 kommentar(er)
